IL143385A0 - 5ht1 antagonists for antidepressant therapy - Google Patents

5ht1 antagonists for antidepressant therapy

Info

Publication number
IL143385A0
IL143385A0 IL14338599A IL14338599A IL143385A0 IL 143385 A0 IL143385 A0 IL 143385A0 IL 14338599 A IL14338599 A IL 14338599A IL 14338599 A IL14338599 A IL 14338599A IL 143385 A0 IL143385 A0 IL 143385A0
Authority
IL
Israel
Prior art keywords
antagonists
antidepressant therapy
antidepressant
therapy
Prior art date
Application number
IL14338599A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL143385A0 publication Critical patent/IL143385A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
IL14338599A 1998-12-28 1999-11-03 5ht1 antagonists for antidepressant therapy IL143385A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11395798P 1998-12-28 1998-12-28
PCT/IB1999/001772 WO2000039128A1 (en) 1998-12-28 1999-11-03 5ht1 antagonists for antidepressant therapy

Publications (1)

Publication Number Publication Date
IL143385A0 true IL143385A0 (en) 2002-04-21

Family

ID=22352526

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14338599A IL143385A0 (en) 1998-12-28 1999-11-03 5ht1 antagonists for antidepressant therapy

Country Status (43)

Country Link
US (1) US6525196B1 (xx)
EP (1) EP1140931B1 (xx)
JP (1) JP2002533463A (xx)
KR (1) KR100417506B1 (xx)
CN (1) CN1332740A (xx)
AP (1) AP2001002188A0 (xx)
AR (1) AR024840A1 (xx)
AT (1) ATE260278T1 (xx)
AU (1) AU761711B2 (xx)
BG (1) BG105710A (xx)
BR (1) BR9916807A (xx)
CA (1) CA2356985C (xx)
CO (1) CO5150179A1 (xx)
CR (1) CR6398A (xx)
CZ (1) CZ291163B6 (xx)
DE (1) DE69915113T2 (xx)
DK (1) DK1140931T3 (xx)
DZ (1) DZ2933A1 (xx)
EA (1) EA003099B1 (xx)
EE (1) EE04439B1 (xx)
ES (1) ES2214892T3 (xx)
GE (1) GEP20043227B (xx)
GT (1) GT199900224A (xx)
HR (1) HRP20010488A2 (xx)
HU (1) HUP0104852A3 (xx)
ID (1) ID30117A (xx)
IL (1) IL143385A0 (xx)
IS (1) IS5951A (xx)
MA (1) MA26706A1 (xx)
NO (1) NO20013215L (xx)
NZ (1) NZ511964A (xx)
OA (1) OA11742A (xx)
PA (1) PA8486701A1 (xx)
PE (1) PE20001234A1 (xx)
PT (1) PT1140931E (xx)
SK (1) SK9002001A3 (xx)
TN (1) TNSN99218A1 (xx)
TR (1) TR200101979T2 (xx)
TW (1) TW523514B (xx)
UA (1) UA62015C2 (xx)
WO (1) WO2000039128A1 (xx)
YU (1) YU44301A (xx)
ZA (1) ZA200105041B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003065970A2 (en) * 2001-02-20 2003-08-14 Royal College Of Surgeons Ie Treatment of fibromyalgia and related fatigue syndromes using pindolol
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
OA13038A (en) * 2003-03-12 2006-11-10 Pfizer Prod Inc Pryridyloxymethyl and benzisoxazole azabicyclic derivatives.
GB0316915D0 (en) * 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
MXPA06008647A (es) * 2004-01-29 2006-09-04 Pfizer Prod Inc Combinaciones de un antipsicotico atipico y derivados azabiciclicos aminometilpiridiloximetil/bencisoxazol para tratar trastornos del sistema nervioso central.
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
AR049478A1 (es) 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
CA2580042A1 (en) * 2004-09-10 2006-03-16 Pfizer Products Inc. Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
US20080318926A1 (en) * 2004-09-10 2008-12-25 Pfizer Inc Methods of Treating Mood Disorders Using Pyridyloxymethyl and Benzisoxazole Azabicyclic Derivatives
DE102005026194A1 (de) * 2005-06-06 2006-12-07 Grünenthal GmbH Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
WO2008019431A1 (en) * 2006-08-14 2008-02-21 Brc Operations Pty Limited Method and compositions for simultaneously regulating memory and mood
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
AU2020407614A1 (en) * 2019-12-20 2022-08-18 The Jackson Laboratory Molecular targets for addiction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
GB9410512D0 (en) * 1994-05-25 1994-07-13 Smithkline Beecham Plc Novel treatment
EP0763034A1 (en) * 1994-05-28 1997-03-19 Smithkline Beecham Plc Amide derivatives having 5ht1d-antagonist activity
NZ500252A (en) * 1997-04-18 2001-07-27 Smithkline Beecham P 6-(4-Methyl-piperazin-1-yl)-1H-indole derivatives useful as 5HT1A, 5HT1B and 5HT1D receptor antagonists
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1

Also Published As

Publication number Publication date
HUP0104852A2 (hu) 2002-05-29
NO20013215D0 (no) 2001-06-27
ATE260278T1 (de) 2004-03-15
DK1140931T3 (da) 2004-04-19
CA2356985A1 (en) 2000-07-06
MA26706A1 (fr) 2004-12-20
SK9002001A3 (en) 2002-04-04
GT199900224A (es) 2001-06-15
AU6361499A (en) 2000-07-31
TW523514B (en) 2003-03-11
PT1140931E (pt) 2004-05-31
OA11742A (en) 2005-05-13
ID30117A (id) 2001-11-08
DE69915113T2 (de) 2004-08-26
EP1140931A1 (en) 2001-10-10
HUP0104852A3 (en) 2002-12-28
AR024840A1 (es) 2002-10-30
PA8486701A1 (es) 2000-09-29
YU44301A (sh) 2004-07-15
BG105710A (en) 2002-02-28
BR9916807A (pt) 2001-10-23
EA200100517A1 (ru) 2001-12-24
CA2356985C (en) 2006-08-08
TNSN99218A1 (fr) 2005-11-10
GEP20043227B (en) 2004-04-26
US6525196B1 (en) 2003-02-25
PE20001234A1 (es) 2000-11-07
DZ2933A1 (fr) 2004-03-15
KR20010092455A (ko) 2001-10-25
ES2214892T3 (es) 2004-09-16
EE200100346A (et) 2002-12-16
TR200101979T2 (tr) 2001-12-21
IS5951A (is) 2001-05-22
EA003099B1 (ru) 2002-12-26
EP1140931B1 (en) 2004-02-25
EE04439B1 (et) 2005-02-15
AP2001002188A0 (en) 2001-06-30
NO20013215L (no) 2001-08-27
CN1332740A (zh) 2002-01-23
WO2000039128A1 (en) 2000-07-06
ZA200105041B (en) 2002-06-20
JP2002533463A (ja) 2002-10-08
DE69915113D1 (de) 2004-04-01
CZ20012386A3 (cs) 2002-02-13
CZ291163B6 (cs) 2003-01-15
HRP20010488A2 (en) 2002-08-31
CO5150179A1 (es) 2002-04-29
KR100417506B1 (ko) 2004-02-05
AU761711B2 (en) 2003-06-05
UA62015C2 (en) 2003-12-15
NZ511964A (en) 2003-08-29
CR6398A (es) 2004-03-24

Similar Documents

Publication Publication Date Title
GB9820113D0 (en) Therapeutic agents
PL347541A1 (en) 5ht1
GB9816263D0 (en) Therapeutic agents
IL143385A0 (en) 5ht1 antagonists for antidepressant therapy
GB9808663D0 (en) Therapeutic agents
GB9812038D0 (en) Therapeutic compound
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9808665D0 (en) Therapeutic compounds
EP1079845A4 (en) NEW THERAPEUTIC SUBSTANCES FOR MACROMOLECULAR STRUCTURES
GB9810092D0 (en) Therapeutic agents
GB9824897D0 (en) Therapeutic compounds
GB9819484D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
SI1140931T1 (en) 5ht1 antagonists for antidepressant therapy
GB9815317D0 (en) Therapeutic agents
GB9805716D0 (en) Therapeutic agents
GB9817838D0 (en) Therapeutic agents
GB9808667D0 (en) Therapeutic compounds
GB9816723D0 (en) Therapeutic agents